Tesaglitazar

DRUG13 trials

Sponsors

AstraZeneca

Conditions

Diabetes Mellitus, Type 2Type 2 Diabetes

Phase 2

ARMOR (Analyzing Renal Mechanisms of Creatinine Excretion in Patients On tesaglitazaR)

TerminatedNCT00229684

AstraZenecaDiabetes Mellitus, Type 2

Start: 2004-09-30End: 2006-06-30Target: 100Updated: 2011-08-30

Dose Response Study in Japanese Patients

TerminatedNCT00261417

AstraZenecaType 2 Diabetes

Start: 2004-05-31End: 2005-10-31Target: 250Updated: 2009-04-22

ARAMIS: Actions of tesaglitazaR on fAt Metabolism and Insulin Sensitivity

TerminatedNCT00263965

AstraZenecaType 2 Diabetes

Start: 2005-08-31End: 2006-07-31Target: 105Updated: 2008-03-17

GLAD: Dose-Finding, Efficacy, and Safety of AZ 242 (Tesaglitazar) in Subjects With Type 2 Diabetes

CompletedNCT00280865

AstraZenecaType 2 Diabetes

Start: 2002-04-30End: 2003-06-30Target: 500Updated: 2006-07-31

Phase 3

GALLEX 6: Study to Evaluate the Safety and Tolerability of Tesaglitazar in Patients With Type 2 Diabetes Mellitus

TerminatedNCT00226330

AstraZenecaDiabetes Mellitus, Type 2

Start: 2005-03-31End: 2006-12-31Target: 1100Updated: 2010-11-19

GALLEX 9: Safety and Tolerability of Oral Tesaglitazar When Added to Insulin Therapy in Patients With Type 2 Diabetes

TerminatedNCT00229710

AstraZenecaDiabetes Mellitus, Type 2

Start: 2005-02-28End: 2006-12-31Target: 270Updated: 2010-11-19

GALLANT 8 Tesaglitazar Add-on to Metformin

TerminatedNCT00251953

AstraZenecaType 2 Diabetes

Start: 2004-07-31End: 2006-03-31Target: 555Updated: 2009-04-22

GALLANT 2 Tesaglitazar vs. Placebo

TerminatedNCT00252772

AstraZenecaType 2 Diabetes

Start: 2004-09-30End: 2006-11-30Target: 80Updated: 2009-04-22

GALLEX 1 - Long Term Extension Study in Patients With Type 2 Diabetes

TerminatedNCT00252876

AstraZenecaType 2 Diabetes

Start: 2005-03-31End: 2007-01-31Target: 2000Updated: 2008-03-17

GALLANT 22 Tesaglitazar vs. Placebo

TerminatedNCT00252837

AstraZenecaType 2 Diabetes

Start: 2005-04-30End: 2006-12-31Target: 475Updated: 2008-03-17

GALLANT 4 Tesaglitazar vs. Glibenclamide

TerminatedNCT00255541

AstraZenecaType 2 Diabetes

Start: 2004-09-30End: 2006-12-31Target: 580Updated: 2008-03-17

GALLANT 14 Tesaglitazar vs. Metformin and Fenofibrate

TerminatedNCT00261352

AstraZenecaType 2 Diabetes

Start: 2005-03-31End: 2006-12-31Target: 1000Updated: 2009-04-22

GALLEX 4 - Long-Term Extension Study to Evaluate Tesaglitazar Therapy in Patients With Type 2 Diabetes

TerminatedNCT00300105

AstraZenecaType 2 Diabetes

Start: 2005-10-31End: 2006-12-31Target: 400Updated: 2008-03-17

Related Papers

How many unpublished studies? ClinicalTrials.gov (n = 2614 studies): diabetes | Closed Studies | Interventional Studies | Phase 3, 4 | Search Date: Oct 27, 2014

Figshare2014-01-01